Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11919877 | 1.00 | TSHR (0.59) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL26664442 | 1.00 | TSHR (0.59) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL27230054 | 1.00 | TSHR (0.59) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL19448719 | 1.00 | TSHR (0.59) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL18031717 | 0.97 | TSHR (0.55) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL12404110 | 0.97 | TSHR (0.60) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL21373942 | 0.95 | TSHR (0.53) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL26363949 | 0.95 | TSHR (0.53) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL331797 | 0.95 | TSHR (0.53) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL3420908 | 0.95 | TSHR (0.53) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240191078-A1 | ULTRAVIOLET-RAY-CURABLE COMPOSITION AND USE THEREOF | DOW TORAY CO LTD (JP) | 2024-06-13 | — | — | US | claimed |
| WO-2022203042-A1 | ULTRAVIOLET-RAY-CURABLE COMPOSITION AND USE THEREOF | ダウ・東レ株式会社 | 2022-09-29 | — | — | WO | claimed |
| WO-2022102626-A1 | ULTRAVIOLET RAY CURABLE COMPOSITION AND APPLICATIONS THEREOF | ダウ・東レ株式会社 | 2022-05-19 | — | — | WO | claimed |
| US-20260022202-A1 | UV-CURABLE COMPOSITION AND USE THEREOF | DOW TORAY CO LTD (JP) | 2026-01-22 | — | — | US | disclosed |
| US-20250368774-A1 | ULTRAVIOLET-CURABLE COMPOSITION AND USE THEREOF | DOW TORAY CO LTD (JP) | 2025-12-04 | — | — | US | disclosed |
| US-20250250378-A1 | CYANONORBORNENE POLYMERS FOR OIL RESISTANT PHOTOIMAGEABLE COMPOSITIONS | PROMERUS, LLC (US) | 2025-08-07 | — | — | US | disclosed |
| US-20250138422-A1 | PHOTOSENSITIVE RESIN COMPOSITION, MANUFACTURING METHOD OF ELECTRONIC DEVICE, AND ELECTRONIC DEVICE | SUMITOMO BAKELITE CO., LTD. (JP) | 2025-05-01 | — | — | US | disclosed |
| WO-2024225072-A1 | PHOTOSENSITIVE RESIN COMPOSITION, PRODUCTION METHOD FOR CURED RELIEF PATTERN, AND CURED FILM | 旭化成株式会社 | 2024-10-31 | — | — | WO | disclosed |
| US-20240288770-A1 | PHOTOSENSITIVE POLYIMIDE COMPOSITIONS | PROMERUS, LLC (US) | 2024-08-29 | — | — | US | disclosed |
| US-20240191078-A1 | ULTRAVIOLET-RAY-CURABLE COMPOSITION AND USE THEREOF | DOW TORAY CO LTD (JP) | 2024-06-13 | — | — | US | disclosed |
| US-20240174889-A1 | ULTRAVIOLET-CURABLE COMPOSITION AND USE THEREOF | DOW TORAY CO LTD (JP) | 2024-05-30 | — | — | US | disclosed |
| US-20100048738-A1 | HYBRID COMPOUNDS BASED ON POLYOL(S) AND AT LEAST ONE OTHER MOLECULAR ENTITY, POLYMERIC OR NON-POLYMERIC, IN PARTICULAR OF THE POLYORGANOSILOXANE TYPE, PROCESS FOR THE PREPARATION THEREOF, AND APPLICATIONS THEREOF | RHODIA OPERATIONS (FR) | 2010-02-25 | — | — | US | disclosed |
| US-20090253609-A1 | HYBRID COMPOUNDS BASED ON SILICONES, AND AT LEAST ONE OTHER MOLECULAR ENTITY, POLYMER OR OTHERWISE, ESPECIALLY OF THE POLYOL TYPE, METHOD FOR THE PREPARATION THEREOF, AND APPLICATIONS OF THE SAME | RHODIA OPERATIONS (FR) | 2009-10-08 | — | — | US | disclosed |
| US-20090186224-A1 | Anti-fouling cationically crosslinkable varnish compositions and support substrates coated therewith | RHODIA CHIMIE (FR) | 2009-07-23 | — | — | US | disclosed |
| US-20090175804-A1 | Preparation of cationic terpolymers and personal care compositions comprising said terpolymers | BASF SE (DE) | 2009-07-09 | — | — | US | disclosed |
| US-20080308225-A1 | Adhesive composition suitable to be applied by screen printing | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2008-12-18 | — | — | US | disclosed |
| US-20080265439-A1 | Die bonding agent and a semiconductor device made by using the same | SHIN-ETSU CHEMICAL CO., LTD. | 2008-10-30 | — | — | US | disclosed |
| US-7326746-B2 | Curable electron donor compositions | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION | 2008-02-05 | — | — | US | disclosed |
| US-7270936-B2 | Negative resist composition comprising hydroxy-substituted base polymer and Si-containing crosslinker having epoxy ring and a method for patterning semiconductor devices using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2007-09-18 | — | — | US | disclosed |
| US-20070060683-A1 | Curable electron donor compositions | HENKEL AG & CO. KGAA (DE) | 2007-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090175804-A1 | Preparation of cationic terpolymers and personal care compositions comprising said terpolymers | CUTA, TERB1, PARG | TSHR 2225/4885SMN1; SMN2 3874/4885ALDH1A1 4217/4885 |
| US-20100048738-A1 | HYBRID COMPOUNDS BASED ON POLYOL(S) AND AT LEAST ONE OTHER MOLECULAR ENTITY, POLYMERIC OR NON-POLYMERIC, IN PARTICULAR OF THE POLYORGANOSILOXANE TYPE, PROCESS FOR THE PREPARATION THEREOF, AND APPLICATIONS THEREOF | PAOX, SQLE, SOST | TSHR 3000/4885SMN1; SMN2 4385/4885ALDH1A1 1816/4885 |
| US-20260022202-A1 | UV-CURABLE COMPOSITION AND USE THEREOF | IDUA, SEM1, ARSA | TSHR 2587/4885SMN1; SMN2 361/4885ALDH1A1 232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.